Sign in
4

Changes in Ownership

Jasper Therapeutics, Inc. Filed Acc 0001213900-23-048683

See Remarks sold 9,000 shares at $1.66 ($14,915)

  • See Remarks acquired 9,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Mahal Jeetinder Singh See Remarks 2023-06-13 Option exercise 10b5-1 +9,000 $0.71 $6,390 296,223 D: show line 1 in the form
Mahal Jeetinder Singh See Remarks 2023-06-13 Sale 10b5-1 −9,000 $1.66 $14,915 287,223 D: show line 2 in the form
Open-market sales · 9,000 sh · avg $1.66 · $14,915

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Mahal Jeetinder Singh See Remarks 2023-06-13 Option exercise · Stock Option (right to buy) 10b5-1 +9,000 173,713 D: show line 3 in the form
Loading xslF345X04/ownership.xml…